Article Details
Retrieved on: 2023-11-13 08:23:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
HC Wainwright currently has a “Buy” rating and a $11.00 target price on the stock. The consensus estimate for Ikena Oncology's current full-year ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here